Feng, H., Li, B., Li, Z., Wei, Q., & Ren, L. (2021). PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma. BMC Cancer.
Stile di citazione ChicagoFeng, Honglei, Bole Li, Ze Li, Qian Wei, e Li Ren. "PIVKA-II Serves As a Potential Biomarker That Complements AFP for the Diagnosis of Hepatocellular Carcinoma." BMC Cancer 2021.
Citazione MLAFeng, Honglei, et al. "PIVKA-II Serves As a Potential Biomarker That Complements AFP for the Diagnosis of Hepatocellular Carcinoma." BMC Cancer 2021.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.